Table 1.

Characteristics of Participants Depending on the Delay from the End of Radiotherapy.

Delay from end of radiotherapy (Number of participants)		<2y (n = 9)	2–5y (n = 10)	>5 y (n = 13)	P-value
Participant characteristics
Age at baseline assessment (years) .007
	Mean	9.72	10.65	13.65
	Standard deviation	1.38	2.87	2.82
	Range	7.5–11.8	7.49–17.0	9.0–16.9
Sex (male)		5 (55.6%)	4 (40.0%)	9 (69.2%)	.386
Handedness (right)		7 (100%)	9 (90%)	12 (92%)	.713
Number of years of education—Mother .241
	Mean	13.8	16.2	15.0
	Standard deviation	1.92	2.49	2.16
	Range	12–17	14–20	12–18
Number of years of education—Father .238
	Mean	15.6	16.6	13.57
	Standard deviation	2.70	2.07	2.64
	Range	11–18	15–20	10–17
Tumor and treatment
Age at diagnosis .180
	Mean	7.18	6.30	5.44
	Standard deviation	2.72	1.99	2.22
	Range	2.25–10.67	3.0–9.17	1.92–9.33
Tumor type .237
	Medulloblastoma	7	7	6
	Ependymoma	2	1	3
	High Grade Glioma	0	0	2
	Germ cell tumor	0	1	1
	Pineoblastoma	0	1	0
	Sarcoma	0	0	1
Tumor location .058
	Infratentorial	9	8	8
	Supratentorial	0	1	5
Chemotherapy		8	9	11	.920
Hydrocephalus .631
	With no treatment	3	1	6
	Requiring CSF diversion	3	6	3
Radiation type .490
	Focal	1	2	6
	Cranio-spinal 23.4 Gy Cranio-spinal 36.0 Gy	2 5	2 5	2 5
Number of surgeries .853
	1 surgery	6	6	8
	2 surgeries	1	2	5
	3 surgeries	1	1	0
Relapse		2	1	1
Exercise level before training
Exercise activity before trial .509
	Everyday	1	1	0
	More than 3 times a week	2	2	5
	Less than 3 times a week	2	1	4
	Sedentary	0	3	0
BMI (z-score) .095
	Mean	−0.164	0.885	0.929
	Standard deviation	1.23	1.01	0.868
	Range	−2.07 to 1.69	−1.09 to 2.24	−0.290 to .56
Intervention
Intervention or control group .273
	Intervention	3	7	6
	Control	6	3	7
Group training or combined training .810
	Group training	2	5	5
	Combined training	4	5	7